The DOI matches its Crossref record; its reference list is not available.
Karyotypic similarity identified by multiplex‐FISH relates four prostate adenocarcinoma cell lines: PC‐3, PPC‐1, ALVA‐31, and ALVA‐41
Abstract
Recently developed molecular cytogenetic techniques for karyotyping are providing new and important insights regarding the chromosomal changes that occur in solid tumors. We used multiplex-FISH to analyze four adenocarcinoma cell lines, PC-3, PPC-1, ALVA-31, and ALVA-41, in which the characterization of a large number of rearranged chromosomes was partially or substantially inconclusive by G-banding. Although the original descriptions of these lines depict them as distinct entities established from different patients, this study demonstrates that these four lines share numerous, highly rearranged chromosomes, strongly supporting the conclusion that they are derived from the same patient material. Our analysis indicates that PPC-1, ALVA-31, and ALVA-41 were derived from PC-3 through mechanisms involving clonal progression represented by sequential changes and clonal diversion represented by differing patterns of changes. Extensive cellular heterogeneity was detected in all four lines, and most rearrangements included segments derived from multiple chromosomes. Each line also showed a set of unique derivative chromosomes. However, a limited number of metaphase cells (approximately 10) was analyzed for each line, and numerous single-cell abnormalities were detected in all of them. Therefore, it is plausible that the number of clonal, shared, and/or unique rearrangements has been underestimated. These cell lines have been utilized as models for understanding the biology of prosta…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
ALVA-31 was originally established in 1993 as a human prostate carcinoma, but was found to be identical to PC-3 in 2001.
“This cell line was originally established in 1993 as a human prostate carcinoma [35], but was found to be identical to a different human prostate carcinoma, the PC-3 cell line, in 2001 [36, 37].”
From The ghosts of HeLa: How cell line misidentification contaminates the scientific literature (2017) · cites this paper as [36]
Citations
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 35 · Cited by 21
Research works printed but not linked: 33
- 10.1002/1098-2264(2000)9999:9999<::AID-GCC1076>3.0.CO;2-E · DOI
- 10.2165/00066982-200005010-00008 · DOI
- 10.1016/S0165-4608(96)00258-0 · DOI
- 10.1159/000133283 · DOI
- 10.1002/ijc.2910440525 · DOI
- 10.1159/000133468 · DOI
- 10.3322/canjclin.50.1.7 · DOI
- 10.1002/(SICI)1097-0045(19980701)36:2<92::AID-PROS4>3.0.CO;2-G · DOI
- 10.1007/978-3-642-60162-0_21 · DOI
- ISCN, 1995, Guidelines for cancer cytogenetics: an international system for human cytogenetics nomenclature
- Kaighn ME, 1979, Establishment and characterization of a human prostatic carcinoma cell line (PC‐3), Invest Urol, 17, 16
- 10.1007/s11626-998-0078-x · DOI
- 10.1002/1098-2264(200007)28:3<308::AID-GCC9>3.0.CO;2-B · DOI
- 10.1002/pros.2990220202 · DOI · Paper page
- Macville M, 1999, Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping, Cancer Res, 59, 141
- 10.1016/S0165-4608(98)00142-3 · DOI
- Miller GJ, 1995, Vitamin D receptor expression, 24‐hydroxylase activity, and inhibition of growth by 1α, 25‐dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines, Clin Cancer Res, 1, 997
- 10.1016/0039-128X(94)90052-3 · DOI
- 10.1002/cyto.990100105 · DOI
- Ohnuki Y, 1980, Chromosomal analysis of human prostatic adenocarcinoma cell lines, Cancer Res, 40, 524
- 10.1002/(SICI)1098-2264(199905)25:1<53::AID-GCC8>3.0.CO;2-T · DOI
- 10.1159/000015432 · DOI · Paper page
- 10.1002/1098-2264(2000)9999:9999<::AID-GCC1075>3.0.CO;2-H · DOI
- 10.1038/sj.neo.7900036 · DOI
- Rao PH, 1998, Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma, Blood, 92, 1743
- Rowley JD, 1999, Spectral karyotype analysis of T‐cell acute leukemia, Blood, 93, 2038, 10.1182/blood.V93.6.2038.406a32_2038_2042 · DOI
- 10.1073/pnas.97.1.303 · DOI
- 10.1182/blood.V92.11.4269.423k31_4269_4278 · DOI
- 10.1126/science.273.5274.494 · DOI
- 10.1038/ng0496-368 · DOI
- 10.1002/pros.1045 · DOI · Paper page
- 10.1038/ng0497-406 · DOI
- 10.1016/S0165-4608(98)00095-8 · DOI
Metadata
- Authors
- Varella‐Garcia, M., Boomer, T., & Miller, G. J.
- Affiliations
- University of Colorado Health (US)
- Corresponding author
- Miller, Gary J.
- Venue
- Genes, Chromosomes and Cancer
- Publisher
- Wiley
- Published
- 2001-05-31
- Volume
- 31
- Issue
- 4
- Pages
- 303-315
- ISSN
- 1045-2257 (ISSN-L)
- 1098-2264
- OpenAlex
- W2053671546
- Cited by
- 21
- References
- 35
- Citations by year
- 2019: 1 · 2018: 1 · 2017: 1 · 2012: 1
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Genes Chromosomes and Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ca053520-06)
- National Cancer Institute (R01CA084269, CA-53520, CA-84269, CA-46934, P30CA046934)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- prostate adenocarcinoma, prostate cancer cell lines, PC-3 cells, clonal evolution, chromosomal rearrangements, derivative chromosomes, cellular heterogeneity, cell line derivation, multiplex FISH
- MeSH terms
- Adenocarcinoma, Chromosome Aberrations, Clone Cells, Genetic Markers, Humans, Karyotyping, Male, Middle Aged, Prostatic Neoplasms, Tumor Cells, Cultured, In Situ Hybridization, Fluorescence, Chromosome Disorders, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review